Kemnay Advisory Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
Kemnay Advisory Services's SRPT Position: Q3 2026 in Review
Kemnay Advisory Services opened a new position in Sarepta Therapeutics (SRPT) in Q3 2026: 954 shares worth $17.4K. The stake represents ﹤0.01% of the portfolio and ranks #587 among its holdings. This is a return to the name: Kemnay Advisory Services previously reported a position in SRPT as recently as Q4 2020.
Kemnay Advisory Services first reported a position in SRPT in Q4 2019 and has held it in 5 quarters since. The position peaked at $2.7M in Q4 2019. 303 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- Kemnay Advisory Services held 954 shares of Sarepta Therapeutics worth $17.4K as of Q3 2026.
- Sarepta Therapeutics was a new Kemnay Advisory Services position in Q3 2026.
- Sarepta Therapeutics made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #587 holding.
- Kemnay Advisory Services first reported a position in Sarepta Therapeutics in Q4 2019 and has held it in 5 quarters since.
- Kemnay Advisory Services's Sarepta Therapeutics position peaked at $2.7M in Q4 2019.
- 303 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.